PHARMA ANALYTICS LTDActive

Company number 11658356Private limited companyIncorporated 2018

Key figures

£35,993+232.2%
Net assets 2024/25
-1.2%
Average annual change 2019/20–2024/25
-50 k-25 k025 k50 k75 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PHARMA ANALYTICS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Turnover—————
Profit for the year—————
Total assets54,04057,1388,4780—
Total liabilities—0—27,22535,993
Net assets / total equity54,04057,1388,478-27,22535,993
Average number of employees11111
Average pay (per year)—————

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMA ANALYTICS LTD

Company

PHARMA ANALYTICS LTD is a private limited company registered with Companies House under company number 11658356. It was incorporated on 5 Nov 2018. Its status is active. The registered office is in London (E16). Its nature of business (SIC 2007) is information technology consultancy activities (62020), data processing, hosting and related activities (63110), management consultancy activities other than financial management (70229), engineering related scientific and technical consulting activities (71122).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Nov 2025); the company files micro-entity accounts. Net assets were £35,993, up 232.2% on the previous year. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Aug 2027. The next confirmation statement is due by 16 Nov 2026.